Vitae Pharmaceuticals Announces Closing of Initial Public Offering
September 29, 2014 10:35 ET
|
Vitae Pharmaceuticals, Inc.
FORT WASHINGTON, Pa., Sept. 29, 2014 (GLOBE NEWSWIRE) -- Vitae Pharmaceuticals, Inc. (Nasdaq:VTAE), a clinical stage biotechnology company, today announced the closing of its initial public offering...
Vitae Pharmaceuticals Announces Pricing of Initial Public Offering
September 24, 2014 09:25 ET
|
Vitae Pharmaceuticals, Inc.
FORT WASHINGTON, Pa., Sept. 24, 2014 (GLOBE NEWSWIRE) -- Vitae Pharmaceuticals, Inc., a clinical stage biotechnology company, today announced the pricing of its initial public offering of 6,875,000...
Vitae Pharmaceuticals Adds to Leadership Team With Appointment of Arthur Fratamico as Chief Business Officer, Richard Morris as Chief Financial Officer
July 08, 2014 08:00 ET
|
Vitae Pharmaceuticals, Inc.
FORT WASHINGTON, Pa., July 8, 2014 (GLOBE NEWSWIRE) -- Vitae Pharmaceuticals, Inc., a clinical-stage biotechnology company focused on discovering and developing small molecule drugs, today announced...